4D pharma plc (LBPSW)

Etorro trading 970x250

About 4D pharma plc

Address: 9 Bond Court, Leeds, United Kingdom, LS1 2JZ

4D pharma plc News and around…

Latest news about 4D pharma plc (LBPSW) common stock and company :

4D pharma to Participate in Jefferies Virtual Next Generation IBD Therapeutics Summit
12 Oct, 2021 Yahoo! Finance

LEEDS, England, October 12, 2021--4D pharma plc (AIM: DDDD, NASDAQ, LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that 4D management will present at the Jefferies Virtual Next Generation IBD Therapeutics Summit being held on October 19, 2021.

4D pharma Presents Two Clinical Posters for Live Biotherapeutic MRx0518 at the European Society for Medical Oncology (ESMO) Congress 2021
15 Sep, 2021 Yahoo! Finance

LEEDS, England, September 15, 2021--4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces new biomarker analyses from two ongoing clinical trials of its lead immuno-oncology single strain Live Biotherapeutic, MRx0518, in both neoadjuvant and refractory solid tumor settings, at the European Society for Medical Oncology (ESMO) Congress, September 16-21, 202

4D pharma to Participate in Upcoming Virtual Investor Conferences in September
09 Sep, 2021 Yahoo! Finance

LEEDS, England, September 09, 2021--4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that 4D pharma management will present at the following virtual investor conferences:

4D pharma Announces Two Presentations at European Society for Medical Oncology (ESMO) Congress 2021
02 Aug, 2021 Yahoo! Finance

LEEDS, England, August 02, 2021--4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces two poster presentations at the European Society for Medical Oncology (ESMO) Congress, held from September 16-21, 2021. The two e-posters will be available from 07:30 BST (02:30 ET) on September 16, 2021.

4D pharma Announces $30 Million Credit Facility with Oxford Finance
29 Jul, 2021 Yahoo! Finance

LEEDS, England, July 29, 2021--4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces the closing of a senior secured credit facility for up to $30m with Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies.

4D pharma Announces Passing of Chief Financial Officer John Beck
26 Jul, 2021 Yahoo! Finance

LEEDS, England, July 26, 2021--4D pharma plc (AIM: DDDD, NASDAQ, LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, announces with great sadness that John Beck, Chief Financial Officer of 4D pharma, has passed away.

4D pharma Announces Publication of Preclinical Research Showing Single Strain Megasphaera massiliensis improves activity of CAR-T
06 Jul, 2021 Yahoo! Finance

LEEDS, England, July 06, 2021--4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces the publication of pre-clinical research relating to its second-generation immuno-oncology LBP MRx1299 improving the activity of CAR-T.

Final Results for the year ended 31 December 2020
01 Apr, 2021 FinancialContent

4D pharma plc (LBPSW) is a NASDAQ Common Stock listed in

970x250